Results 111 to 120 of about 53,326 (163)

A Case of Cutaneous T-cell Lymphoma: The Importance of a Dermatology Consultation. [PDF]

Cureus
Tobar JA, Silva V, Tan V, Khalil K.
europepmc   +1 more source

Inducible Costimulator and Its Ligand Promote Proliferation and Migration of Tumor Cells in Cutaneous T-Cell Lymphoma. [PDF]

Int J Mol Sci
Oka K, Miyagawa T, Morita H, Suga H, Miyagaki T, Shibata S, Kamijo H, Mizuno Y, Hisamoto T, Omori I, Boki H, Oka T, Takahashi-Shishido N, Sugaya M, Sato S.   +14 more
europepmc   +1 more source

IQDMA disrupts STAT5 nuclear transport through CDC42-PAK2 axis collapse in cutaneous T-cell lymphoma. [PDF]

Front Immunol
Dey S, Sorger H, Schlederer M, Perchthaler I, Metzelder M, Kenner L, Moriggl R, Wolf P.   +7 more
europepmc   +1 more source

NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell Lymphoma. [PDF]

Cancer Sci
Takahashi Y, Kitadate A, Iwama S, Kuroki W, Abe K, Yamada M, Ikeda S, Tagawa H, Wakui H, Hikida M, Takahashi N.   +10 more
europepmc   +1 more source

Moderate-Dose Local Radiotherapy in Symptomatic CD30-Positive, Anaplastic Lymphoma Kinase (ALK)-Negative Primary Cutaneous T-cell Lymphoma. [PDF]

Cureus
Varela A, Sepúlveda S, Evans NE, Araúz RE, Champsaur LM, D Orcy E, Samudio O.   +6 more
europepmc   +1 more source

Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis. [PDF]

J Dtsch Dermatol Ges
Schummer P, Glatzel C, Schrüfer P, Lawrenz I, Dobos G, Wehkamp U, Hüning S, Stranzenbach R, Nicolay JP, Goebeler M, Wobser M.   +10 more
europepmc   +1 more source

Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphoma. [PDF]

Bone Marrow Transplant
Krämer I, König L, Brecht A, Hassel JC, Luft T, Hegenbart U, Eichkorn T, Stadtherr P, Müller-Tidow C, Dreger P.   +9 more
europepmc   +1 more source

T-cell receptor gamma (TRG) diversity predicts peripheral blood involvement in primary cutaneous T-cell lymphoma. [PDF]

Blood Neoplasia
Ramesh R, Colbourn R, Van Deerlin VM, Halper-Stromberg E.   +3 more
europepmc   +1 more source

Evaluating mogamulizumab in the treatment of primary cutaneous T-cell lymphoma. [PDF]

Immunotherapy
Oymanns M, Elsayad K, Wilms L, Dimmers F, Daum-Marzian M, Abu-Dawud R, Motiei M, Assaf C.   +7 more
europepmc   +1 more source